alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › improved

improved

4 studies tagged improved, dated 2014-12-04 to 2022-03-12. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease 2022-03-12
  2. Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein 2020-09-18
  3. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region 2015-03-05

Studies

4 studies carry this tag.

Date range

2014 to 2022

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Brain research 1
  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1
  • NeuroImage 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-03-12 Biomarkers

    We conclude that the Aβ 37/42 ratio sensitively detects presenilin/γ-secretase dysfunction and better distinguishes CN from AD than Aβ42/40 in CSF.

  2. Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Brain research 2020-09-18 Brain scans and imaging

    The neuropathological hallmark of Parkinsońs disease, multiple system atrophy and dementia with Lewy bodies is the accumulation of α-synuclein.

  3. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015-03-05 Brain scans and imaging

    A cerebral white matter reference region may improve the power to track longitudinal fibrillar Aβ increases, to characterize their relationship to longitudinal clinical declines, and to evaluate Aβ-modifying treatments in randomized clinical trials.

  4. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. NeuroImage 2014-12-04 Brain scans and imaging

    Amyloid positron-emission-tomography (PET) offers an important research and diagnostic tool for investigating Alzheimer's disease (AD).

All topic tags with their study counts